GLP-1 drugs may result in better outcomes for cancer patients, a new study has claimed.
While GLP-1 drugs, such as Ozempic and Wegovy, are most commonly known for their weight-loss results, they were initially developed to treat type 2 diabetes.
GLP-1 drugs may result in better outcomes for cancer patients, a new study has claimed.
While GLP-1 drugs, such as Ozempic and Wegovy, are most commonly known for their weight-loss results, they were initially developed to treat type 2 diabetes.